Skip to content

Clinical trials

Phase 3 Carcinoma, Intraductal, Noninfiltrating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Phase: Phase 3 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20071
20083
20091
20101
20112
20151
20162
20191
20201
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting3
Not yet recruiting1
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology3
National Cancer Institute (NCI)2
Radiation Therapy Oncology Group2
Academic and Community Cancer Research United1
Andrea DeCensi1
ETOP IBCSG Partners Foundation1
Fudan University1
Georgetown University1
Gustave Roussy, Cancer Campus, Grand Paris1
NRG Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating22
Breast Neoplasms16
Breast Carcinoma In Situ10
Breast Neoplasms, Male1
Endometrial Neoplasms1
Hot Flashes1
Neoplasm Recurrence, Local1
Osteoporosis1
Paget's Disease, Mammary1
Radiation Injuries1

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.